RefloDx Wins Trans Atlantic Angel Grand Prize
July 10, 2025
RefloDx competed in a field of 81 companies worldwide and won the grand prize investment from the Trans Atlantic Angel Competition 7 on June 12. The diligence team scrutinized financial projections, commercialization, regulatory, and reimbursement strategies, as well as IP review, and conducted detailed interviews with advisors, clinicians, and the RefloDx management team, including Rudy Wilcox, CEO, and Greg Critchfield, MD, MS, executive chair.
BioUtah congratulates RefloDx, which also won their category in the 2025 Entrepreneur & Investor Summit pitch competition.
Recent News
- Canyon Labs Launches Expanded Reprocessing Validation Services for Medical Devices
- Connecting with Life Sciences in Logan
- Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- Ratio Therapeutics Enters into Research Collaboration, License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
- Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
- Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
